Linked Life Data

12521199

Source:http://linkedlifedata.com/resource/pubmed/id/12521199

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
12
pubmed:dateCreated
2003-1-10
pubmed:abstractText
We attempted to evaluate the feasibility (therapeutic efficacy, tolerance, and clinical courses after treatment) of pirfenidone, an anti-fibrotic drug for patients with chronic pulmonary fibroses such as idiopathic pulmonary fibrosis (IPF).
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Dec
pubmed:issn
0918-2918
pubmed:author
pubmed:issnType
Print
pubmed:volume
41
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
1118-23
pubmed:dateRevised
2006-11-15
pubmed:meshHeading
pubmed:year
2002
pubmed:articleTitle
Open-label compassionate use one year-treatment with pirfenidone to patients with chronic pulmonary fibrosis.
pubmed:affiliation
Department of Respiratory Medicine, Graduate School of Medicine, Kyoto University, Kyoto.
pubmed:publicationType
Journal Article, Comparative Study, Research Support, Non-U.S. Gov't